The CCL11 gene helps make a signaling protein that draws eosinophils, a type of white blood cell, to tissues during allergic reactions and some parasite infections. What this gene does can influence how your body handles airway and skin inflammation. If its signals are too strong or too weak, eosinophils may gather in the wrong amount, which can contribute to problems such as asthma, nasal allergies, or eczema. Most CCL11 variants are not a single-gene cause of illness on their own.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes carry the code for producing proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes take place, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
CCL11Gene function
What if the gene works
The CCL11 gene helps direct eosinophils, a type of white blood cell, to places where your body is responding to allergies or parasites. This supports normal immune signaling and inflammation.
Risk
What if the gene does not work
If the CCL11 gene does not work properly, cells may make less eotaxin-1, weakening signals that guide eosinophils. Variants can range from milder to more severe and may change how much of this signaling protein is produced.
Treatment
What does that mean for your treatment
No CCL11-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the CCL11 gene. The CCL11 gene is being studied mainly as a biomarker in allergic airway disease and other inflammatory conditions, rather than a guide to drug choice in routine care.
Gene function
What if the gene works
Your immune system depends on small chemical signals that guide white blood cells through the body. The CCL11 gene helps make one of these signals, with a strong role in directing eosinophils. This is part of how the body organizes routine immune traffic in tissues such as the airways, skin, and gut.
The CCL11 gene’s main function in the immune system is to attract eosinophils, a type of white blood cell. Its protein gives these cells a clear signal about where to travel in the body.
The protein made from the CCL11 gene acts as a chemical messenger between cells. It attaches to CCR3 (a docking site on certain immune cells) and helps those cells move in a directed way.
This gene supports normal immune cell movement in barrier tissues that contact the outside world, including the lungs, skin, and digestive tract. That steady traffic helps the body place the right cells in the right location.
The CCL11 gene works with other immune signals rather than acting alone. Together, these signals help organize immune responses used at body surfaces and during parasite defense.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
CCL11 gene variants can change how much eotaxin-1 a cell makes or releases, or alter the protein’s shape so receptor binding is weaker. Milder variants may slightly shift signaling, while more disruptive variants can sharply lower protein levels or create a shortened protein that is unstable. Variants in control regions may also change when or where the CCL11 gene is switched on inside cells.
How variants are linked to conditions
Current evidence on how CCL11 gene variants are linked to conditions is still developing. The CCL11 gene does not yet have a broadly confirmed link to a specific health condition, and anyone with a confirmed CCL11-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are common across the population and are a normal feature of human biology. Most do not directly affect health and instead reflect the usual range of human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CCL11 gene itself. CCL11 has been studied in areas like allergy, inflammation, and aging, but personal risk usually depends on many genes along with environment and overall health; anyone concerned about their own risk can speak with a doctor or genetic counselor.
Inheritance of CCL11 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the CCL11 gene, so the inheritance of the CCL11 gene variants is not described as a clear autosomal dominant or autosomal recessive condition. Research has linked some CCL11 variants to differences in risk for inflammatory or allergy related traits, but these findings do not show a single predictable family pattern. The CCL11 gene is located on chromosome 17, which is an autosome, so you inherit one copy from each parent.
What does my CCL11 result mean for my family?
There is not yet a broadly confirmed inherited pattern tying CCL11 changes to a specific, well-established genetic condition in families, though this can become clearer as research grows. If you have a specific CCL11 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CCL11 gene, a lab uses a blood sample, saliva sample, or cheek swab to read the gene’s DNA code. CCL11 genetic testing usually checks for specific variants or includes the gene as part of a larger panel, and results show whether a variant was found, not whether a health problem will definitely occur.
When should I consider getting a genetic test?
There is not yet a broadly established CCL11-specific clinical reason for genetic testing. Decisions about testing are usually based on your personal health and family history, best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, yet the amount it explains varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help frame individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people taking the same treatment may not get the same result because their bodies can absorb, break down, transport, or respond to a drug differently. These inherited differences are common and can influence how well a medicine works or how likely someone is to be more sensitive to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medication. It looks at the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can help support more informed, individualized treatment decisions. To explore this subject in more detail, you can read more in the LearnHub.
Drugs influenced by the CCL11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for changes in this gene in guiding medication response, so questions about treatment, side effects, or your overall health are best discussed with your doctor.
History
The CCL11 gene entered the scientific literature in the 1990s, during a period when researchers were sorting out a growing family of immune signaling genes. It was first identified through work on allergic inflammation, especially asthma, where scientists were trying to understand why certain white blood cells gathered in the airways. From these first observations, research expanded steadily. As naming systems became more standardized, this gene came to be known as CCL11, replacing the earlier name eotaxin in many scientific contexts. Its discovery helped shape a broader shift in allergy and inflammation research, linking specific inherited signals to patterns doctors had long observed in people with asthma and other allergic conditions.